Latest News
From the Journals
Screening blood donations for Zika proved costly, low yield
Testing blood donations confirmed only 8 authentic Zika cases and cost nearly $42 million over 15 months.
Feature
Uninsured rate on the rise
New survey shows that Medicaid expansion lessened the effect.
Feature
HHS says no to lifetime limits on Medicaid
The Trump administration’s promise of unprecedented flexibility to states in running their Medicaid programs hit its limit on May 7.
From the Journals
Adding vasopressin in distributive shock may cut AF risk
Adding vasopressin cut risk of atrial fibrillation, compared with catecholamine vasopressors alone.
Latest News
New trial to assess HIV+/HIV+ kidney transplants
NIH announces clinical trial to track outcomes of kidney transplantation from HIV+ donors to HIV+ recipients.
Conference Coverage
Where the latest HCV drug combos fit in
MAUI, HAWAII – The biggest remaining challenge in the treatment of hepatitis C is to gain improved access to therapy, according to Steven L. Flamm...
Conference Coverage
Don’t shorten therapy for older, sicker cellulitis patients
Elderly patients with cellulitis and comorbid conditions probably need a full 12-day course of treatment.
News from the FDA/CDC
Inadequate antibiotic use persists in gonorrhea
In 2016, about one in five gonorrhea cases did not receive recommended treatment.
From the Journals
Very few infants born to HCV-infected mothers receive testing
Despite increasing prevalence of hepatitis C virus infection in pregnant women, infants exposed to the disease are screened at a very low rate.
Conference Coverage
Most HIV patients need treatment for acute HCV
Fewer than 12% of HIV infected men will clear new hepatitis C infections on their own and thus need DAA treatment.
Latest News
Phase 2 ‘universal flu vaccine’ trial announced
NIAID announced that is sponsoring a phase 2 trial of a universal flu vaccine, M-001, which could protect against many current and emerging...